These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28935919)

  • 21. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
    Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
    Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 24. Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task.
    Simpson JA; McCaw J; Fowkes FJ
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1172. PubMed ID: 26826193
    [No Abstract]   [Full Text] [Related]  

  • 25. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens.
    Hoshen MB; Na-Bangchang K; Stein WD; Ginsburg H
    Parasitology; 2000 Sep; 121 ( Pt 3)():237-46. PubMed ID: 11085244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of artemisinin-resistant malaria in western Cambodia.
    Noedl H; Se Y; Schaecher K; Smith BL; Socheat D; Fukuda MM;
    N Engl J Med; 2008 Dec; 359(24):2619-20. PubMed ID: 19064625
    [No Abstract]   [Full Text] [Related]  

  • 29. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria.
    Li Q; Lugt CB; Looareesuwan S; Krudsood S; Wilairatana P; Vannaphan S; Chalearmrult K; Milhous WK
    Am J Trop Med Hyg; 2004 Dec; 71(6):723-31. PubMed ID: 15642961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waking the sleeping beauty.
    Nosten F
    J Infect Dis; 2010 Nov; 202(9):1300-1. PubMed ID: 20863226
    [No Abstract]   [Full Text] [Related]  

  • 32. How "resistant" is artemisinin resistant malaria? - The risks of ambiguity using the term "resistant" malaria.
    Hanscheid T; Hardisty DW
    Travel Med Infect Dis; 2018; 24():23-24. PubMed ID: 29715560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.
    Sugiarto SR; Moore BR; Makani J; Davis TME
    Clin Infect Dis; 2018 Feb; 66(5):799-804. PubMed ID: 29370347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
    Jones S; Hodel EM; Sharma R; Kay K; Hastings IM
    J Infect Dis; 2019 Apr; 219(8):1243-1253. PubMed ID: 30517708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reply to "Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task".
    Hastings IM; Kay K; Hodel EM
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1173-4. PubMed ID: 26826194
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.
    Krause A; Dingemanse J; Mathis A; Marquart L; Möhrle JJ; McCarthy JS
    Br J Clin Pharmacol; 2016 Aug; 82(2):412-21. PubMed ID: 27062080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model system to define pharmacokinetic requirements for antimalarial drug efficacy.
    Bakshi RP; Nenortas E; Tripathi AK; Sullivan DJ; Shapiro TA
    Sci Transl Med; 2013 Oct; 5(205):205ra135. PubMed ID: 24089407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Degradation Systems as Antimalarial Therapeutic Targets.
    Ng CL; Fidock DA; Bogyo M
    Trends Parasitol; 2017 Sep; 33(9):731-743. PubMed ID: 28688800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Clinical Pharmacology in Chemotherapy of Multidrug-Resistant Plasmodium falciparum.
    Karbwang J; Na-Bangchang K
    J Clin Pharmacol; 2020 Jul; 60(7):830-847. PubMed ID: 32108367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans.
    Rebelo M; Pawliw R; Gower J; Webb L; Mitchell H; Pava Z; Watts RE; Davenport MP; McCarthy JS; Khoury DS
    J Infect Dis; 2021 Jun; 223(12):2154-2163. PubMed ID: 33119072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.